The Market LogEnter at least 2 characters. Company and ticker searches are not case-sensitive.

Reporting owner

Van Hoose Kyri K.

Reporting owner CIK 0001860885 · SVP, CFO

View SEC filings ↗

These transactions appear in filings associated with this reporting owner. Jointly reported quantities and amounts are unallocated; they are not this owner's individual purchases or total holdings. Names and roles reflect the relevant filing, and a reporting owner may be a person or an organization.

Reset

Transaction timeline

Who reported an acquisition, and when the transaction occurred.

Reported acquisitions by transaction dateEach row is a reporting owner. Select a marker to open its transaction details. Jointly reported transactions appear for each associated reporting owner, without dividing quantities or amounts.Van Hoose Kyri K.Van Hoose Kyri K.Van Hoose Kyri K. · December 23, 2025 · Stock award · Warrant (Right to Buy)Van Hoose Kyri K. · December 23, 2025 · Other acquisition · Warrant (Right to Buy)Van Hoose Kyri K. · December 23, 2025 · Stock award · Series D Warrant (Right to Buy)Van Hoose Kyri K. · December 23, 2025 · Stock award · Series C Warrant (Right to Buy)Van Hoose Kyri K. · December 23, 2025 · Stock award · Common StockDec 23, 2025Dec 23, 2025
PurchaseStock awardGift receivedExercise / conversionConversionOther acquisition

5 dated transactions · 1 of 1 reporting owners shown. Select one owner to focus the chart.

View timeline as a table
Transaction dateCompany / securityReporting ownersAcquisition type
Dec 23, 2025Dermata Therapeutics, Inc.Warrant (Right to Buy)Van Hoose Kyri K.Stock award
Dec 23, 2025Dermata Therapeutics, Inc.Warrant (Right to Buy)Van Hoose Kyri K.Other acquisition
Dec 23, 2025Dermata Therapeutics, Inc.Series D Warrant (Right to Buy)Van Hoose Kyri K.Stock award
Dec 23, 2025Dermata Therapeutics, Inc.Series C Warrant (Right to Buy)Van Hoose Kyri K.Stock award
Dec 23, 2025Dermata Therapeutics, Inc.Common StockVan Hoose Kyri K.Stock award

Only transactions on this page are shown. Date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.

Transactions in associated filings

Reported insider acquisitions, ordered by filing date, newest first. Currency is shown only when reported.
Filed / transactedCompanyReporting ownersType / securityQuantityPrice / reference valueDetails
Trade: Dermata Therapeutics, Inc.DRMA · company listingsStock awardWarrant (Right to Buy)Derivative security · Code A7,874Not reported *Value: Not reportedCurrency not specifiedView ↗
Trade: Dermata Therapeutics, Inc.DRMA · company listingsOther acquisitionWarrant (Right to Buy)Derivative security · Code D7,874Not reported *Value: Not reportedCurrency not specifiedView ↗
Trade: Dermata Therapeutics, Inc.DRMA · company listingsStock awardSeries D Warrant (Right to Buy)Derivative security · Code A122,549Not reported *Value: Not reportedCurrency not specifiedView ↗
Trade: Dermata Therapeutics, Inc.DRMA · company listingsStock awardSeries C Warrant (Right to Buy)Derivative security · Code A122,549Not reported *Value: Not reportedCurrency not specifiedView ↗
Trade: Dermata Therapeutics, Inc.DRMA · company listingsStock awardCommon StockNon-derivative security · Code A122,549Not reported *Value: Not reportedCurrency not specifiedView ↗